OROPHARYNGEAL SQUAMOUS CELL CARCINOMA
Clinical trials for OROPHARYNGEAL SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new OROPHARYNGEAL SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for OROPHARYNGEAL SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could less radiation mean fewer side effects for throat cancer patients?
Disease control Not yet recruitingThis study is testing whether doctors can safely lower radiation doses for people with HPV-positive throat cancer to reduce side effects while still keeping the cancer under control. It will enroll 132 adults who are having either surgery followed by radiation or radiation as the…
Matched conditions: OROPHARYNGEAL SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: University of Maryland, Baltimore • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
Doctors test new 'Lattice' radiation approach to shrink throat tumors before main treatment
Disease control Not yet recruitingThis study is testing a new treatment approach for advanced throat cancer that hasn't spread to distant organs. Researchers want to see if combining targeted radiation (called 'lattice' radiotherapy) with chemotherapy and immunotherapy can shrink tumors before patients receive th…
Matched conditions: OROPHARYNGEAL SQUAMOUS CELL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: NYU Langone Health • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
Trial aims to reduce harsh side effects of cancer radiation
Disease control Not yet recruitingThis study is testing a more personalized approach to radiation therapy given after surgery for head and neck cancer. The goal is to see if doctors can safely target radiation to smaller, specific areas to reduce common and severe side effects, without increasing the risk of the …
Matched conditions: OROPHARYNGEAL SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: Olgun Elicin • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
New scan could spare cancer patients harsh side effects
Disease control Not yet recruitingThis trial is testing whether a special scan can help doctors target radiation more precisely for throat cancer. Currently, patients receive radiation to both sides of the neck, which causes more side effects. The study will see if using this scan to guide treatment to only the a…
Matched conditions: OROPHARYNGEAL SQUAMOUS CELL CARCINOMA
Phase: NA • Sponsor: UNICANCER • Aim: Disease control
Last updated Mar 18, 2026 14:55 UTC